NYSE:MMM - 3M Stock Price, Price Target & More

3M trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMM."

3M announced a quarterly dividend on Tuesday, May 8th. Shareholders of record on Friday, May 18th will be paid a dividend of $1.36 per share on Tuesday, June 12th. This represents a $5.44 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Thursday, May 17th. View 3M's Dividend History.

3M Co (NYSE:MMM) announced its quarterly earnings results on Tuesday, April, 24th. The conglomerate reported $2.50 earnings per share for the quarter, hitting analysts' consensus estimates of $2.50. The conglomerate earned $8.28 billion during the quarter, compared to the consensus estimate of $8.21 billion. 3M had a return on equity of 50.11% and a net margin of 12.83%. The business's revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.16 EPS. View 3M's Earnings History.

3M is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for 3M.

3M issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided EPS guidance of $10.20-10.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.54.

16 Wall Street analysts have issued 12 month price targets for 3M's stock. Their forecasts range from $200.00 to $285.00. On average, they expect 3M's share price to reach $229.6667 in the next twelve months. This suggests a possible upside of 13.7% from the stock's current price. View Analyst Ratings for 3M.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 3M in the last year. There are currently 4 sell ratings, 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to 3M include Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

News articles about MMM stock have been trending positive on Tuesday, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. 3M earned a coverage optimism score of 0.32 on Accern's scale. They also gave headlines about the conglomerate an impact score of 46.79 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

3M's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (0.09%), Swedbank (0.09%), Alecta Pensionsforsakring Omsesidigt (0.08%), Retirement Systems of Alabama (0.07%), Gateway Investment Advisers LLC (0.06%) and Welch & Forbes LLC (0.04%). Company insiders that own 3M stock include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Julie L Bushman, Khandpur K Ashish, Kimberly F Price, Marlene Mary Mcgrath, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Institutional Ownership Trends for 3M.

MMM stock was sold by a variety of institutional investors in the last quarter, including Sabal Trust CO, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Capital One National Association, NN Investment Partners Holdings N.V., Radnor Capital Management LLC, Manning & Napier Group LLC, Fjarde AP Fonden Fourth Swedish National Pension Fund and Riverbridge Partners LLC. Company insiders that have sold 3M company stock in the last year include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Khandpur K Ashish, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Insider Buying and Selling for 3M.

MMM stock was bought by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Confluence Investment Management LLC, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Gofen & Glossberg LLC IL, Calamos Advisors LLC, Benson Investment Management Company Inc. and Park National Corp OH. View Insider Buying and Selling for 3M.

Shares of MMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMM stock can currently be purchased for approximately $202.07.

3M has a market capitalization of $119.44 billion and generates $31.66 billion in revenue each year. The conglomerate earns $4.86 billion in net income (profit) each year or $9.17 on an earnings per share basis. 3M employs 91,536 workers across the globe.

3M's mailing address is 3M CENTER BLDG. 220-11W-02, ST PAUL MN, 55144. The conglomerate can be reached via phone at 651-733-1110.